Clinical Trial Update: Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating olanzapine for prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: CCTU | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED